Pharmacy “Medical Mall” Faces Hardship Due to Dispensing Fee Revision, Profitability Decline Expected to Accelerate M&A – Nikkei

News Highlights

The dispensing fee revision for fiscal year 2026 is expected to reduce the profitability of “medical mall pharmacies” located within facilities housing multiple medical institutions, leading to an acceleration of M&A. The impact on the revenue structure of pharmacies is anticipated to be particularly significant in medical malls where medical, dental, and dispensing services are integrated. Instead of closing down or going out of business due to reasons such as a lack of successors or declining profits, third-party succession is emerging as a notable option.Lack of Successor

Perspective from M&A Medical Editorial Department

This dispensing fee revision carries the potential to shake the very foundation of the revenue structure, especially for pharmacies in medical malls that integrate medical, dental, and dispensing services. It is anticipated that the revision, which aims to promote enhanced pharmacy functions and efficiency rather than simply lowering drug prices, will directly squeeze the profitability of medical mall pharmacies that have historically enjoyed stable earnings. Consequently, third-party succession will likely emerge as a realistic option for pharmacy owners who have previously hesitated to pursue M&A due to issues like a lack of successors or a commitment to regional healthcare. In particular, consolidation within a region or integration into larger pharmacy groups with broader networks are expected to accelerate, not merely as business sales, but as means to secure new revenue bases and improve operational efficiency.

Points Highlighted by This News

• The significant direct impact of the dispensing fee revision on the revenue structure of medical mall pharmacies
• The potential for revenue pressure, particularly on pharmacies in integrated medical, dental, and dispensing malls
• Third-party succession becoming a more viable option for resolving successor issues
• The possibility of diversification and acceleration of M&A, such as regional consolidation and integration into larger groups

Practical Questions Arising from This News

• Which specific items in the current dispensing fee revision will most affect the profitability of medical mall pharmacies?
• If profitability declines, is there potential for coverage through collaboration with other medical departments within the medical mall?
• What are the specific considerations when contemplating third-party succession in the unique environment of a medical mall?

If You Feel “Should I Consult?”

If your pharmacy is located within a medical mall and you are concerned about the impact of the current dispensing fee revision on your revenue, early consultation is crucial. If a lack of successor is already apparent, the options may narrow in conjunction with declining profits. We recommend starting discussions with specialists well-versed in medical M&A to accurately grasp your current revenue structure and the impact of the revision, and to explore possibilities for business continuity and development, including third-party succession.

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics as a Small and Medium Enterprise Agency-certified M&A support institution, on a complete success fee basis. Consultations are handled with strict confidentiality. Free consultation here